Issued Patents 2022
Showing 1–9 of 9 patents
| Patent # | Title | Co-Inventors | Date |
|---|---|---|---|
| 11530420 | Nucleic acid construct | Shaun Cordoba | 2022-12-20 |
| 11492408 | Bi-specific T-cell engager specific for BCMA | Kwee Yong, Lydia Lee, Neil Chaplin | 2022-11-08 |
| 11479613 | Methods for treating cancer or modulating T cells or NK cells in a subject by administering cells comprising chimeric transmembrane proteins | Shaun Cordoba, Matteo Righi, James Sillibourne, Shimobi Onuoha, Simon Thomas | 2022-10-25 |
| 11479614 | Methods for treating cancer or modulating T cells or NK cells in a subject with cancer by administering cells comprising chimeric cytokine receptors | Shaun Cordoba, Matteo Righi, James Sillibourne, Shimobi Onuoha, Simon Thomas | 2022-10-25 |
| 11466070 | Signalling system | Shaun Cordoba, Simon Thomas, Shimobi Onuoha, Maria Stavrou | 2022-10-11 |
| 11385233 | Methods of depleting malignant T-cells | Paul Maciocia | 2022-07-12 |
| 11365262 | Cell | Shaun Cordoba, Matteo Righi, James Sillibourne | 2022-06-21 |
| 11345734 | Chimeric T cell | Shaun Cordoba, Simon Thomas, Khai Kong | 2022-05-31 |
| 11242377 | Chimeric receptor with ligand binding exodomain and cytokine and T cell signalling endodomains | Shaun Cordoba, Matteo Righi | 2022-02-08 |